1. Purdue joining pharma’s top settlement list alongside Merck, GSK, and Pfizer — Biosimilars running into more roadblocks in the US — Big Pharma companies pay for exclusive access to UK genetic data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

NeutraSal /onset Feb 2018 launch!

Discussion in 'Orapharma' started by anonymous, Jan 10, 2017 at 11:38 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    2018 might be a better idea! Maybe by then all the offices will forget what a piece of crap these products are and how horribly OraPharma launched them. It is so embarrassing at this point that my offices will probably ask me to leave if I even mention them being relaunched. Dump these products and call it quits. You have destroyed whatever momentum we had with these products. They should focus on new products and how to save Arestin.
     
  2. anonymous

    anonymous Guest

    Does anyone know how many Onset dental buffering customers there are at present? Is it only in the U.S.? Any info would be appreciated.